Does Aeromonas hydrophila preferentially colonize the bowels of patients with hematologic malignancies?

• Published in: Diagnostic microbiology and infectious disease Vol. 7; no. 1; pp. 63 - 68
• Main Authors: Sherlock, C.H., Burdge, D.R., Smith, J.A.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.05.1987; Elsevier
• Subjects: Adult; Aeromonas - isolation & purification; Anti-Bacterial Agents - therapeutic use; Bacterial diseases; Bacterial diseases of the digestive system and abdomen; Bacterial Infections - complications; Bacterial Infections - drug therapy; Biological and medical sciences; Bone Marrow Transplantation; Feces - microbiology; Female; Human bacterial diseases; Humans; Infectious diseases; Leukemia, Myeloid, Acute - complications; Lymphoproliferative Disorders - complications; Male; Medical sciences; Middle Aged; Neutropenia - etiology; Human; Gut; Aeromonas hydrophila; Malignant hemopathy; Infection; Immunosuppression; Risk factor; Bacteriosis; Bone marrow; Bacteria; Vibrionaceae; Digestive diseases; Feces; Neutropenia
• ISSN: 0732-8893; 1879-0070
• DOI: 10.1016/0732-8893(87)90072-1

Weekly cultures of stools from neutropenic patients and bone marrow transplant recipients yielded Aeromonas hydrophila from 8% of 88 patients over a 2-yr period. During this time stools in the routine enteric laboratory yielded A . hydrophila in 0.24% of 1632 patients. Although the patient groups and culture methods were not directly comparable, this significant difference in isolation rate ( p < 0.001) may reflect a higher colonization rate in the immunocompromised patient.